Skip to main content
Premium Trial:

Request an Annual Quote

Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study

NEW YORK (GenomeWeb) – Biocartis announced today that it has partnered with AstraZeneca on a European study designed to obtain faster lung cancer molecular diagnostics results.

As part of the agreement, the firms will begin a prospective lung cancer study using Biocartis' Idylla EGFR mutation test in European countries including Belgium, France, Germany, and Italy.

Biocartis highlighted that the study will demonstrate how Idylla, a fully automated real-time PCR-based testing platform, can overcome the complexity and long turnaround time of molecular testing for lung cancer patients by delivering faster and accurate biomarker results.

Financial details regarding the agreement and addition information about the prospective clinical study were not disclosed.

"With this prospective study, we expect once again to demonstrate the positive impact of delivering highly accurate biomarker results in a fast and easy way," Biocartis CEO Herman Verrelst said in a statement.

Biocartis said earlier this month that it is adjusting its guidance for 2018, increasing its projection for new instrument placements and narrowing expectations for cartridge volume. The firm also presented lung adenocarcinoma data on the EGFR assay last month during a presentation at the Association for Molecular Pathology annual meeting.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.